These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 18302310
21. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy. Miron P, Côté YP, Lambert J. Prenat Diagn; 2008 Mar; 28(3):180-5. PubMed ID: 18264956 [Abstract] [Full Text] [Related]
22. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600 [Abstract] [Full Text] [Related]
23. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH. Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214 [Abstract] [Full Text] [Related]
24. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Linskens IH, Spreeuwenberg MD, Blankenstein MA, van Vugt JM. Prenat Diagn; 2009 Jan; 29(1):74-8. PubMed ID: 19173346 [Abstract] [Full Text] [Related]
25. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Leung TY, Sahota DS, Chan LW, Law LW, Fung TY, Leung TN, Lau TK. Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339 [Abstract] [Full Text] [Related]
26. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13+6 weeks of gestation. Kagan KO, Frisova V, Nicolaides KH, Spencer K. Prenat Diagn; 2007 Sep; 27(9):849-53. PubMed ID: 17590888 [Abstract] [Full Text] [Related]
27. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Canini S, Prefumo F, Pastorino D, Crocetti L, Afflitto CG, Venturini PL, De Biasio P. Fertil Steril; 2008 Jan; 89(1):174-8. PubMed ID: 17509577 [Abstract] [Full Text] [Related]
28. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases. Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H. Acta Obstet Gynecol Scand; 2006 Jan; 85(5):534-8. PubMed ID: 16752230 [Abstract] [Full Text] [Related]
29. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH. Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925 [Abstract] [Full Text] [Related]
30. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]. Dimitrova V, Chernev T, Vragaleva S, Slŭncheva B, Mikhaĭlova E, Kremenski I, Simeonov E. Akush Ginekol (Sofiia); 2002 Sep; 41(6):3-12. PubMed ID: 12577497 [Abstract] [Full Text] [Related]
31. Comparison of first-trimester contingent screening strategies for Down syndrome. Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK. Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660 [Abstract] [Full Text] [Related]
32. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency. Cowans NJ, Stamatopoulou A, Spencer K. Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026 [Abstract] [Full Text] [Related]
33. First-trimester prediction of birth weight. Boucoiran I, Djemli A, Taillefer C, Rypens F, Delvin E, Audibert F. Am J Perinatol; 2013 Sep; 30(8):665-72. PubMed ID: 23283804 [Abstract] [Full Text] [Related]
34. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070 [Abstract] [Full Text] [Related]
35. First trimester screening for Down syndrome in rhesus negative women. Muhcu M, Mungen E, Atay V, Ipcioglu OM, Dundar O, Ergur R, Yergok YZ. Prenat Diagn; 2008 May; 28(5):404-7. PubMed ID: 18318000 [Abstract] [Full Text] [Related]
36. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Tul N, Novak-Antolic Z. Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793 [Abstract] [Full Text] [Related]
37. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Wright D, Spencer K, Nix B. Prenat Diagn; 2007 Dec; 27(12):1118-22. PubMed ID: 17960785 [Abstract] [Full Text] [Related]
38. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Spencer K. Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476 [Abstract] [Full Text] [Related]
39. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Law LW, Leung TY, Sahota DS, Chan LW, Fung TY, Lau TK. Ultrasound Obstet Gynecol; 2009 Sep; 34(3):283-7. PubMed ID: 19670336 [Abstract] [Full Text] [Related]
40. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Spencer K, Cowans NJ, Nicolaides KH. Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]